Sanofi traded at 100.56 this Friday June 24th, increasing 4.81 or 5.02 percent since the previous trading session. Looking back, over the last four weeks, Sanofi gained 3.05 percent. Over the last 12 months, its price rose by 13.95 percent. Looking ahead, we forecast Sanofi to be priced at 96.96 by the end of this quarter and at 86.91 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
100.56
Daily Change
5.02%
Yearly
13.95%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 152.34 2.89 1.93% 34.84%
Aena 129.85 -0.05 -0.04% -12.29%
Alcon AG 66.14 1.40 2.16% 2.45%
Almirall SA 10.59 0.13 1.24% -29.35%
Amgen 245.37 2.28 0.94% 1.11%
Amarin 1.92 -0.07 -3.52% -58.44%
Artemis Alpha 301.00 2.00 0.67% -30.00%
AstraZeneca 10,776.00 396.00 3.82% 26.79%
Bayer 57.79 -0.75 -1.28% 11.59%
Biogen 211.93 0.55 0.26% -39.09%
BMW 74.94 0.04 0.05% -18.90%
Bristol-Myers Squibb 78.96 1.27 1.63% 18.31%
Daimler 58.56 -0.02 -0.03% -24.70%
Vinci 87.75 2.55 2.99% -5.91%
Essilor 146.55 5.00 3.53% -5.77%
Fresenius Medical Care 47.09 0.93 2.01% -32.77%
Fresenius 28.10 0.54 1.96% -36.83%
Genmab 2,232.00 69.00 3.19% -14.48%
Gilead Sciences 63.08 0.50 0.80% -7.07%
Galapagos 52.24 0.94 1.83% -13.08%
GRIFOLS 18.53 -0.09 -0.46% -18.23%
GlaxoSmithKline 1,756.20 36.60 2.13% 24.27%
Hikma Pharmaceutical 1,637.00 90.50 5.85% -32.33%
J&J 182.29 2.63 1.46% 11.01%
Eli Lilly 325.62 12.90 4.13% 41.44%
Lonza Group 512.80 24.80 5.08% -22.42%
Merck 164.80 8.70 5.57% 4.01%
Merck & Co 93.13 1.13 1.23% 20.63%
Novartis 80.60 2.37 3.03% -4.80%
Orion 37.73 -0.45 -1.18% 3.00%
Pfizer 51.59 1.50 2.99% 32.35%
Philips 20.61 1.06 5.43% -51.39%
Recordati 41.86 2.97 7.64% -13.28%
Regeneron Pharmaceuticals 612.49 5.10 0.84% 11.25%
Roche Holding 318.80 12.50 4.08% -7.54%
Sanofi 100.56 4.81 5.02% 13.95%
SAP 92.33 2.95 3.30% -21.54%
UCB 80.94 -0.74 -0.91% -6.71%
Volkswagen 139.18 0.12 0.09% -35.55%

Indexes Price Day Year
EU50 3533 96.88 2.82% -14.26%
FR40 6073 190.02 3.23% -8.30%
EU100 1158 33.99 3.02% -9.76%

Sanofi
Sanofi SA is a healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme, among others.